Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab

Karan Seegobin, Muhamad A. Moustafa, Nicole Gannon, Katelyn Keller, Jacquelyn Hastings, Vivek Gupta, Han W. Tun, Liuyan Jiang

Research output: Contribution to journalArticlepeer-review

Abstract

IgG4-related disease (IgG4RD) with intracranial involvement is rare. We report a 56-year-old male who had an excellent response to rituximab and dexamethasone after going undiagnosed for 5 years. After 3 years of rituximab maintenance, he has no evidence of disease on brain MRI.

Original languageEnglish (US)
Pages (from-to)1610-1614
Number of pages5
JournalClinical Case Reports
Volume9
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • IgG4 disease
  • headache
  • lymphoproliferative disorder
  • maintenance rituximab
  • pachymeningitis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab'. Together they form a unique fingerprint.

Cite this